Business highlights * eASC technology platform * Patient recruitment for the European Phase III study of Cx601 in complex perianal fistulas in Crohn's disease is 95% complete and is expected to finish ahead of schedule.
http://ift.tt/1qmonWu
http://ift.tt/1qmonWu
No comments:
Post a Comment